Workup of Markedly Elevated Ferritin in Patients with Chronic Inflammatory Disease

Interpretation of Ferritin Elevation

Ferritin can rise markedly in chronic inflammatory conditions without true iron overload; in the general population, iron overload is not the most common cause of an elevated ferritin level. 1, 2, 3, 4
A normal transferrin saturation (< 45 %) reliably distinguishes inflammation‑related hyperferritinemia from hereditary hemochromatosis. 1, 5
Ankylosing spondylitis, as a chronic inflammatory disease, is known to elevate ferritin independent of iron stores. 2, 4

Repeat iron studies (serum ferritin and transferrin saturation) to confirm the initial results. 1, 2
Verify that transferrin saturation remains < 45 % on repeat testing; if it is ≥ 45 %, proceed to HFE genotyping for hereditary hemochromatosis. 1, 5, 2
Obtain liver enzymes (ALT, AST) and platelet count as part of a baseline hepatic assessment. 1, 5, 6

When transferrin saturation is ≥ 45 %, HFE genotyping is indicated to evaluate for hereditary hemochromatosis. 1, 5
Normal transferrin saturation makes hereditary hemochromatosis highly unlikely; inflammation is the probable explanation for the ferritin rise. 2, 4
In patients with biochemical iron overload (elevated TS + high ferritin) or when the etiology remains unclear after excluding common causes, liver MRI with R2* quantification should be considered. 7

A ferritin > 1000 µg/L combined with elevated aminotransferases and a platelet count < 200 × 10⁹/L predicts cirrhosis in ~80 % of patients with hereditary hemochromatosis; however, normal iron studies make true iron overload unlikely in this scenario. 1, 5, 6
Screen for alternative hepatic contributors to hyperferritinemia, including non‑alcoholic fatty liver disease, alcohol use, and viral hepatitis. 1, 2

Order a complete blood count to exclude hematologic malignancies, particularly lymphoma, which commonly produces markedly elevated ferritin. 1, 2

Although not directly cited, assessment for active infection is prudent in patients receiving immunomodulatory therapy such as secukinumab.

Liver MRI with R2* quantification is reserved for patients who have both elevated transferrin saturation and ferritin, or when the cause of hyperferritinemia remains unidentified after comprehensive laboratory workup. 7
Liver biopsy for iron quantification is only indicated when there is evidence of cirrhosis or persistent diagnostic uncertainty after non‑invasive testing and true iron overload is suspected. 7, 1

Do not order HFE genotyping when transferrin saturation is normal; this yields unnecessary testing without impacting management. 1, 5
Do not assume iron overload based solely on a high ferritin level; in chronic inflammatory diseases, ferritin is a nonspecific acute‑phase reactant. 2, 4
Do not overlook malignancy as a potential cause of markedly elevated ferritin; appropriate cancer screening and CBC are essential.

Evaluate secondary causes (liver enzymes, platelet count, CBC, age‑appropriate cancer screening, assessment of inflammatory disease activity). 1
Proceed to HFE genotyping for hereditary hemochromatosis. 1, 5
Treat the underlying condition and monitor ferritin trends. 1
Consider hepatic MRI with R2* for quantitative iron assessment. 7